Kyushu Central Hospital
Fukuoka 815-8588
1 studies enrolling now · 4 studies all time
What they study most
Acute Non-cardioembolic Ischemic Stroke, Asthma, Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Elevated Lp(a), High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism
Studies at this site
- Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication — Completed
- A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
- A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early